Paul J. Neeson

9.5k total citations
144 papers, 4.2k citations indexed

About

Paul J. Neeson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Paul J. Neeson has authored 144 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Oncology, 81 papers in Immunology and 35 papers in Molecular Biology. Recurrent topics in Paul J. Neeson's work include Immune Cell Function and Interaction (50 papers), CAR-T cell therapy research (43 papers) and Cancer Immunotherapy and Biomarkers (41 papers). Paul J. Neeson is often cited by papers focused on Immune Cell Function and Interaction (50 papers), CAR-T cell therapy research (43 papers) and Cancer Immunotherapy and Biomarkers (41 papers). Paul J. Neeson collaborates with scholars based in Australia, United States and France. Paul J. Neeson's co-authors include David Ritchie, H. Miles Prince, Phillip K. Darcy, Simon J. Harrison, Mark J. Smyth, Joseph A. Trapani, Hang Quach, Michael H. Kershaw, Paul A. Beavis and A. Keith Stewart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Paul J. Neeson

137 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul J. Neeson Australia 33 2.4k 1.9k 1.4k 757 467 144 4.2k
Gunnar Kvalheim Norway 43 2.9k 1.2× 1.8k 1.0× 1.7k 1.2× 595 0.8× 311 0.7× 173 5.5k
Stéphane Depil France 29 2.4k 1.0× 1.6k 0.8× 1.7k 1.2× 220 0.3× 549 1.2× 70 4.0k
Sebastian Kobold Germany 36 3.3k 1.4× 2.7k 1.4× 1.7k 1.2× 297 0.4× 775 1.7× 141 5.5k
Jacalyn Rosenblatt United States 31 1.7k 0.7× 1.2k 0.6× 1.5k 1.0× 1.3k 1.7× 223 0.5× 142 3.5k
Saar Gill United States 39 4.4k 1.8× 3.0k 1.6× 2.0k 1.4× 1.1k 1.5× 1.0k 2.2× 174 6.9k
Kevin J. Curran United States 32 3.6k 1.5× 1.3k 0.7× 1.9k 1.4× 440 0.6× 973 2.1× 94 5.3k
Angelica Loskog Sweden 37 2.8k 1.2× 2.2k 1.2× 1.3k 0.9× 200 0.3× 420 0.9× 103 4.6k
Marcus O. Butler Canada 42 4.8k 2.0× 3.6k 1.9× 1.7k 1.2× 236 0.3× 396 0.8× 248 6.9k
Benjamin G. Vincent United States 34 2.6k 1.1× 3.0k 1.6× 1.7k 1.2× 193 0.3× 874 1.9× 104 5.3k
Nicole M. Haynes Australia 31 2.3k 1.0× 2.6k 1.4× 1.1k 0.8× 130 0.2× 386 0.8× 58 4.2k

Countries citing papers authored by Paul J. Neeson

Since Specialization
Citations

This map shows the geographic impact of Paul J. Neeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Neeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Neeson more than expected).

Fields of papers citing papers by Paul J. Neeson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Neeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Neeson. The network helps show where Paul J. Neeson may publish in the future.

Co-authorship network of co-authors of Paul J. Neeson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Neeson. A scholar is included among the top collaborators of Paul J. Neeson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Neeson. Paul J. Neeson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antón, A., Ryan Hutchinson, Christopher M. Hovens, et al.. (2024). An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape. PLoS ONE. 19(11). e0301943–e0301943. 3 indexed citations
2.
Sun, Shicheng, Ali Motazedian, Joe Jiang Zhu, et al.. (2024). Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis. Nature Communications. 15(1). 7698–7698. 1 indexed citations
3.
Bressel, Mathias, Yi-An Ko, Anne Hamilton, et al.. (2024). Beacon: A phase II study of bevacizumab, atezolizumab, and cobimetinib in patients with recurrent, platinum resistant, high grade serous ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5565–5565. 1 indexed citations
4.
Eapen, Renu, Scott Williams, Sean Macdonald, et al.. (2024). Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer. Nature Reviews Urology. 21(11). 676–686. 6 indexed citations
5.
Yang, Tianpei, Maria Doyle, Angela Pizzolla, et al.. (2023). Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments. Nature Communications. 14(1). 2697–2697. 38 indexed citations
6.
Giuffrida, Lauren, Kevin Sek, Melissa A. Henderson, et al.. (2021). CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy. Nature Communications. 12(1). 3236–3236. 150 indexed citations
7.
Mills, Jane K., Melissa A. Henderson, Lauren Giuffrida, et al.. (2021). Generating CAR T cells from tumor-infiltrating lymphocytes. SHILAP Revista de lepidopterología. 9. 955837343–955837343. 11 indexed citations
8.
Keam, Simon P., Heloise M. Halse, Thu Quynh Nguyen, et al.. (2020). High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot. Journal for ImmunoTherapy of Cancer. 8(1). e000792–e000792. 51 indexed citations
9.
Li, Jessica, Sarah Whelan, Maya F. Kotturi, et al.. (2020). PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia. Haematologica. 106(12). 3115–3124. 23 indexed citations
10.
Terry, Rachael, Déborah Meyran, David S. Ziegler, et al.. (2020). Immune profiling of pediatric solid tumors. Journal of Clinical Investigation. 130(7). 3391–3402. 27 indexed citations
11.
Giuffrida, Lauren, Kevin Sek, Melissa A. Henderson, et al.. (2020). IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors. Molecular Therapy. 28(11). 2379–2393. 74 indexed citations
12.
Davenport, Alexander J., Ryan Cross, Katherine A. Watson, et al.. (2018). Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity. Proceedings of the National Academy of Sciences. 115(9). E2068–E2076. 244 indexed citations
13.
Gherardin, Nicholas A., Liyen Loh, Alexander J. Davenport, et al.. (2018). Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma. Scientific Reports. 8(1). 4159–4159. 77 indexed citations
14.
Halse, Heloise M., Andrew J. Colebatch, Pasquale Petrone, et al.. (2018). Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma. Scientific Reports. 8(1). 11158–11158. 74 indexed citations
15.
Mardiana, Sherly, Liza B. John, Melissa A. Henderson, et al.. (2017). A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells. Cancer Research. 77(6). 1296–1309. 63 indexed citations
16.
Dushyanthen, Sathana, Zhi L. Teo, Franco Caramia, et al.. (2017). Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer. Nature Communications. 8(1). 606–606. 96 indexed citations
17.
Slaney, Clare Y., Bianca von Scheidt, Alexander J. Davenport, et al.. (2016). Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. Clinical Cancer Research. 23(10). 2478–2490. 89 indexed citations
18.
Davenport, Alexander J., Misty R. Jenkins, Ryan Cross, et al.. (2015). CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells. Cancer Immunology Research. 3(5). 483–494. 112 indexed citations
19.
Paget, Christophe, Helene Duret, Maya Hassane, et al.. (2015). CD3(bright) signals on gamma delta T cells identify IL-17A-producing V gamma 6V delta 1( ) T cells. Immunology and Cell Biology. 93(2). 2 indexed citations
20.
Westwood, Jennifer A., Maria Moeller, Connie P.M. Duong, et al.. (2010). Tumor Ablation by Gene-Modified T Cells in the Absence of Autoimmunity. Cancer Research. 70(23). 9591–9598. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunnar Kvalheim Breakdown of academic impact, for papers by Stéphane Depil Breakdown of academic impact, for papers by Sebastian Kobold Breakdown of academic impact, for papers by Jacalyn Rosenblatt Breakdown of academic impact, for papers by Saar Gill Breakdown of academic impact, for papers by Kevin J. Curran Breakdown of academic impact, for papers by Angelica Loskog Breakdown of academic impact, for papers by Marcus O. Butler Breakdown of academic impact, for papers by Benjamin G. Vincent Breakdown of academic impact, for papers by Nicole M. Haynes
Rankless by CCL
2026